Augusta Gold Corp. (AUGG) is expected to report for Q2 2024
Amplitude Inc. (AMPL) is expected to report $-0.18 for Q2 2024
Cadiz Inc. (CDZI) is expected to report $-0.1 for Q2 2024
DAQO New Energy Corp. American Depositary Shares each representing five (DQ) is expected to report $-0.24 for Q2 2024
Artelo Biosciences Inc. (ARTL) is expected to report $-0.83 for Q2 2024
Array Technologies Inc. (ARRY) is expected to report $0.08 for Q2 2024
1895 Bancorp of Wisconsin Inc. (BCOW) is expected to report for Q2 2024
Biote Corp. (BTMD) is expected to report $0.09 for Q2 2024
Cheniere Energy Partners LP (CQP) is expected to report $0.83 for Q2 2024
Americold Realty Trust Inc. (COLD) is expected to report $0.31 for Q2 2024
Anika Therapeutics Inc. (ANIK) is expected to report $-0.06 for Q2 2024
Avalo Therapeutics Inc. (AVTX) is expected to report $-6.7 for Q2 2024
Barinthus Biotherapeutics plc American Depositary Shares (BRNS) is expected to report $-0.42 for Q2 2024
Blend Labs Inc. Class A (BLND) is expected to report $-0.1 for Q2 2024
Celcuity Inc. (CELC) is expected to report $-0.71 for Q2 2024
Algoma Steel Group Inc. (ASTL) is expected to report $-0.09 for Q1 2025
CarGurus Inc. (CARG) is expected to report $0.23 for Q2 2024
Cannae Holdings Inc. (CNNE) is expected to report $-0.29 for Q2 2024
Arlo Technologies Inc. (ARLO) is expected to report $-0.06 for Q2 2024
CI Financial Corp. (CIXXF) is expected to report for Q2 2024
Cogent Communications Holdings Inc. (CCOI) is expected to report $-1.31 for Q2 2024
Danimer Scientific Inc. (DNMR) is expected to report $-0.24 for Q2 2024
Acorn Energy Inc (ACFN) is expected to report for Q2 2024
Bloom Energy Corporation Class A (BE) is expected to report $-0.16 for Q2 2024
BlackSky Technology Inc. Class A (BKSY) is expected to report $-0.09 for Q2 2024
CION Investment Corporation (CION) is expected to report for Q2 2024
Atlanta Braves Holdings Inc. Series C Common Stock (BATRK) is expected to report $0.41 for Q2 2024
Burford Capital Limited (BUR) is expected to report $0.34 for Q2 2024
Avenue Therapeutics Inc. (ATXI) is expected to report for Q2 2024
Affimed N.V. (AFMD) is expected to report $-1 for Q2 2024
Consensus Cloud Solutions Inc. (CCSI) is expected to report $1.11 for Q2 2024
Cemtrex Inc. (CETX) is expected to report for Q3 2024
Douglas Emmett Inc. (DEI) is expected to report $0.43 for Q2 2024
AuthID Inc Com (New) (AUID) is expected to report for Q2 2024
Carisma Therapeutics Inc. (CARM) is expected to report $-0.36 for Q2 2024
Cosan S.A. ADS (CSAN) is expected to report for Q2 2024
Codexis Inc. (CDXS) is expected to report $-0.26 for Q2 2024
Apyx Medical Corporation (APYX) is expected to report $-0.18 for Q2 2024
Sendas Distribuidora S A ADS (ASAI) is expected to report $0.07 for Q2 2024
Applied DNA Sciences Inc. (APDN) is expected to report $-0.64 for Q3 2024
Altus Power Inc. Class A (AMPS) is expected to report $0.03 for Q2 2024
Cano Health Inc. Class A (CANOQ) is expected to report for Q2 2024
Aprea Therapeutics Inc. (APRE) is expected to report $-0.63 for Q2 2024
Better Home & Finance Holding Company (BETR) is expected to report for Q2 2024
Arhaus Inc. (ARHS) is expected to report $0.13 for Q2 2024
Amplifon (AMFPF) is expected to report for Q2 2024
Cibus Inc. (CBUS) is expected to report $-0.81 for Q2 2024
Allianz SE ADR (ALIZY) is expected to report $0.64 for Q2 2024
Backblaze Inc. (BLZE) is expected to report $-0.28 for Q2 2024
Cresco Labs Inc. (Sub Voting) (CRLBF) is expected to report $-0.01 for Q2 2024
ATAI Life Sciences N.V. (ATAI) is expected to report $-0.17 for Q2 2024
Artivion Inc Com (AORT) is expected to report $0.03 for Q2 2024
Brookdale Senior Living Inc. (BKD) is expected to report $-0.13 for Q2 2024
AlloVir Inc. (ALVR) is expected to report $-0.1 for Q2 2024
Birchcliff Energy Ltd (BIREF) is expected to report for Q2 2024
Aptose Biosciences Inc. (APTO) is expected to report $-0.58 for Q2 2024
Autolus Therapeutics plc (AUTL) is expected to report $-0.19 for Q2 2024
Viridien ADR (CGGYD) is expected to report for Q2 2024
Akamai Technologies Inc. (AKAM) is expected to report $1.06 for Q2 2024
PlayAGS Inc. (AGS) is expected to report $0.11 for Q2 2024
Comera Life Sciences Holdings Inc. (CMRA) is expected to report for quarter end 2024-06-30
BioAtla Inc. (BCAB) is expected to report $-0.45 for Q2 2024
Amylyx Pharmaceuticals Inc. (AMLX) is expected to report $-0.38 for Q2 2024
ATS Corporation (ATS) is expected to report $0.4 for Q1 2025
CURO Group Holdings Corp. (CUROQ) is expected to report for Q2 2024
Akili Inc. (AKLI) is expected to report for Q2 2024
Choice Hotels International Inc. (CHH) is expected to report $1.87 for Q2 2024
Powerfleet, Inc. (AIOT) is expected to report $0 for Q2 2024
Brookfield Corporation Class A Limited (BN) is expected to report $0.78 for Q2 2024
Acacia Research Corporation (ACTG) is expected to report for Q2 2024
BKF Capital Group Inc (BKFG) is expected to report for Q2 2024
Dillard's Inc. (DDS) is expected to report $5.91 for Q2 2025
AvePoint Inc. (AVPT) is expected to report $-0.03 for Q2 2024
Almaden Minerals Ltd. (AAUAF) is expected to report for Q2 2024
Deutsche Telekom AG ADR (DTEGY) is expected to report for Q2 2024
Cyrela Brazil Realty S.A. ADR (CYRBY) is expected to report for quarter end 2024-06-30
Accelerate Diagnostics Inc. (AXDX) is expected to report $-0.55 for Q2 2024
ALX Oncology Holdings Inc. (ALXO) is expected to report $-0.77 for Q2 2024
Aware Inc. (AWRE) is expected to report for Q2 2024
Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.14 for Q2 2024
Cars.com Inc. (CARS) is expected to report $0.35 for Q2 2024
Cognition Therapeutics Inc. (CGTX) is expected to report $-0.22 for Q2 2024
Atlanta Braves Holdings Inc. Series A Common Stock (BATRA) is expected to report $0.32 for Q2 2024
Avnet Inc. (AVT) is expected to report $0.95 for Q4 2024
AN2 Therapeutics Inc. (ANTX) is expected to report $-0.63 for Q2 2024
CareRx Corporation (CHHHF) is expected to report $-0.01 for Q2 2024
Candel Therapeutics Inc. (CADL) is expected to report for Q2 2024
ADMA Biologics Inc (ADMA) is expected to report $0.08 for Q2 2024
Avinger Inc. (AVGR) is expected to report $-0.43 for Q2 2024
CalciMedica Inc. (CALC) is expected to report $-0.55 for Q2 2024
Benson Hill Inc. (BHIL) is expected to report $-2.1 for Q2 2024
Mosaic ImmunoEngineering (CPMV) is expected to report for Q2 2024
Century Aluminum Company (CENX) is expected to report $0.02 for Q2 2024
Cullinan Therapeutics Inc. (CGEM) is expected to report $-0.73 for Q2 2024
AMN Healthcare Services Inc (AMN) is expected to report $0.75 for Q2 2024
Creditriskmonitor.com, Inc. (CRMZ) is expected to report for Q2 2024
Alarm.com Holdings Inc. (ALRM) is expected to report $0.31 for Q2 2024
CONSOL Energy Inc. (CEIX) is expected to report $1.28 for Q2 2024
Adverum Biotechnologies Inc. (ADVM) is expected to report $-1.27 for Q2 2024
Amprius Technologies Inc. (AMPX) is expected to report $-0.11 for Q2 2024
Archer Aviation Inc. Class A (ACHR) is expected to report $-0.38 for Q2 2024
Bonterra Energy Corp. (BNEFF) is expected to report for Q2 2024
CRH PLC (CRH) is expected to report $1.87 for Q2 2024
Ducommun Incorporated (DCO) is expected to report $0.63 for Q2 2024
ProFrac Holding Corp. (ACDC) is expected to report $0.14 for Q2 2024
Euronav NV (CMBT) is expected to report $0.29 for Q2 2024
Arrowhead Pharmaceuticals Inc. (ARWR) is expected to report $-0.58 for Q3 2024
Ginkgo Bioworks Holdings Inc. Class A (DNA) is expected to report $-0.08 for Q2 2024
Bitfarms Ltd. (BITF) is expected to report $-0.11 for Q2 2024
Aveanna Healthcare Holdings Inc. (AVAH) is expected to report $-0.04 for Q2 2024
Altimmune Inc. (ALT) is expected to report $-0.34 for Q2 2024
Akebia Therapeutics Inc. (AKBA) is expected to report $-0.06 for Q2 2024
Autoscope Technologies Corporation (AATC) is expected to report for Q2 2024
Cidara Therapeutics Inc. (CDTX) is expected to report $-3.94 for Q2 2024
Avadel Pharmaceuticals plc (AVDL) is expected to report $-0.17 for Q2 2024
Credicorp Ltd. (BAP) is expected to report $4.64 for Q2 2024
Axogen Inc. (AXGN) is expected to report $-0.14 for Q2 2024
Delta Apparel Inc. (DLAPQ) is expected to report for Q3 2024
Agenus Inc. (AGEN) is expected to report $-1.33 for Q2 2024
Allied Gaming & Entertainment Inc. (AGAE) is expected to report for Q2 2024
Brookfield Reinsurance Ltd. Class A Exchangeable Limited (BNRE) is expected to report for Q2 2024
Compumed, Inc. (CMPD) is expected to report for Q3 2024
CG Oncology, Inc. (CGON) is expected to report $-0.42 for Q2 2024
Doximity Inc. Class A (DOCS) is expected to report $0.16 for Q1 2025
SmartCentres Real Estate Investment Trust Unit (Variable Voating) (CWYUF) is expected to report for Q2 2024
Brilliant Earth Group Inc. (BRLT) is expected to report $-0.02 for Q2 2024
Boyd Group Services Inc (BYDGF) is expected to report for Q2 2024
BanColombia S.A. (CIB) is expected to report $1.43 for Q2 2024
Biolase Inc. (BIOL) is expected to report for Q2 2024
Liberty Media Corp. (Tracking Stock - Braves) Series B (BATRB) is expected to report for Q2 2024
Babcock & Wilcox Enterprises Inc. (BW) is expected to report $0.08 for Q2 2024
American Realty Investors Inc. (ARL) is expected to report for Q2 2024
Chesapeake Utilities Corporation (CPK) is expected to report $0.88 for Q2 2024
Bragg Gaming Group Inc. (BRAG) is expected to report for Q2 2024
DermTech Inc (DMTKQ) is expected to report for Q2 2024
Cabaletta Bio Inc. (CABA) is expected to report $-0.55 for Q2 2024
Cherry Hill Mortgage Investment Corporation (CHMI) is expected to report $0.15 for Q2 2024
DigitalOcean Holdings Inc. (DOCN) is expected to report $0.18 for Q2 2024
Aterian Inc. (ATER) is expected to report for Q2 2024
Air Transport Services Group Inc (ATSG) is expected to report $0.16 for Q2 2024
BioLife Solutions Inc. (BLFS) is expected to report $-0.14 for Q2 2024
Capri Holdings Limited (CPRI) is expected to report $0.59 for Q1 2025
Aptevo Therapeutics Inc. (APVO) is expected to report $-1.93 for Q2 2024
